Compare JAKK & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JAKK | TMCI |
|---|---|---|
| Founded | 1995 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 292.0M | 292.0M |
| IPO Year | 1996 | 2021 |
| Metric | JAKK | TMCI |
|---|---|---|
| Price | $25.26 | $4.50 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 6 |
| Target Price | ★ $35.00 | $4.77 |
| AVG Volume (30 Days) | 42.0K | ★ 204.3K |
| Earning Date | 04-30-2026 | 05-08-2026 |
| Dividend Yield | ★ 4.65% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $331,249,000.00 | $212,690,000.00 |
| Revenue This Year | $9.46 | N/A |
| Revenue Next Year | $4.36 | $8.18 |
| P/E Ratio | $188.77 | ★ N/A |
| Revenue Growth | N/A | ★ 1.59 |
| 52 Week Low | $14.87 | $1.17 |
| 52 Week High | $27.22 | $7.08 |
| Indicator | JAKK | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 57.64 | 46.78 |
| Support Level | $24.51 | $4.28 |
| Resistance Level | $26.35 | $4.67 |
| Average True Range (ATR) | 0.56 | 0.21 |
| MACD | 0.09 | -0.02 |
| Stochastic Oscillator | 100.00 | 27.78 |
Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells, and distributes toys and related kid-targeted consumer products, including kids' indoor and outdoor furniture, costumes, and various product lines in the sporting goods and home furnishings space. Its product offerings include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: Toys/Consumer Products and Costumes. It generates the majority of its revenue from the Toys/Consumer Products segment.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.